 |
|
|
| |
Projected impact and pathways to success of the hepatitis C virus elimination program in Georgia, 2015-2020
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
from Jules: Amazing, Georgia is on a path to eliminate HCV, but the USA nor NYS cannot figure out how to configure any program. Granted gilead donated the drug and the CDC helped, but you mean to tell me the US federal government is not able to come up with ideas on how to do something like this. Of course they can, they just have no will or resolve to even try to figure it out because its not important to US politicians. Congress has already funded such a program for the VA, why?? Because that is politically important to getting re-elected, but the remainder if the HCV+ population gets nothing from Congress, WHY? Because its not politically important to re-election, because it looks bad to ignore vets, but they others with HCV are not important to their image. Its Congress & The White House that hold the power to implement an HCV Elimination Program, but they refuse, the same in NYS, officials can negotiate with drug makers and configure a plan but they do nit want to, its that simple.
Josephine Walker1, Liesl Hagan2, Hannah Fraser1, Natasha K Martin9,1, Juliette Morgan7, Muazzam Nasrullah2, Francisco Averhoff2, David Otiashvili3, Ivdity Chikovani4, Malvina Aladashvili11, Mark H. Kuniholm10, Irma Kirtadze3, David Baliashvili5, Lia Gvinjilia6, Alexander Asatiani5, Ketevan Stvilia5, Irma Khonelidze5, Maia Butsashvili12, Tengiz Tsertsvadze11, Amiran Gamkrelidze5, Valeri Kvaratskhelia8, Peter Vickerman1
1University of Bristol 2. CDC, 3. Addiction Research Center Alternative Georgia 4. Curatio International Foundation 5. NCDC Georgia 6. CDC Foundation 7. South Caucasus CDC Office 8. Ministry of Labor Health and Social Affairs of Georgia 9. UC San Diego 10. University at Albany, SUNY 11. Infectious Diseases, AIDS and Clinical Immunology Research Center 12. Neolab
|
| |
|
|
|
|
|
